Loading clinical trials...
Loading clinical trials...
The purpose of this noncomparative study is to obtain preliminary estimates of the efficacy of erlotinib and standard chemotherapy in patients with advanced, previously untreated nonsmall cell lung ca...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
OSI Pharmaceuticals
NCT06043817 · Non-Small Cell Lung Cancer, NSCLC, and more
NCT07144280 · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, and more
NCT07431827 · Non-small Cell Lung Cancer
NCT06758401 · Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, and more
NCT06427941 · Metastatic Hepatocellular Carcinoma, Local Advanced Hepatocellular Carcinoma, and more
California Cancer Care, Inc.
Greenbrae, California
Sharp Clinical Oncology Research
San Diego, California
Holy Cross Hospital
Fort Lauderdale, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions